Coronavirus Q&A With Anthony Fauci, MD

FromJAMA Author Interviews

Start listening View podcast show

Coronavirus Q&A With Anthony Fauci, MD

FromJAMA Author Interviews

ratings:

Length:

27 minutes

Released:

Jun 4, 2020

Format:

Podcast episode

Description

NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020. Related Article: Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism

Released:

Jun 4, 2020

Format:

Podcast episode

Titles in the series (100)

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.

Skip carousel

What If Physicians Actually Had to Control Medical Costs?: Interview with Robert H. Brook, MD, ScD, author of What If Physicians Actually Had to Control Medical Costs? by JAMA Author Interviews
6 min listen
Physician Communication in the 21st Century: Interview with Allan S. Detsky, MD, PhD, author of Physician Communication in the 21st Century by JAMA Author Interviews
8 min listen
Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries: Interview with Lawrence O. Gostin, JD, author of Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries by JAMA Author Interviews
8 min listen
Understanding Depression and Distress Among Medical Students: Interview with Laura Weiss Roberts, MD, MA, author of Understanding Depression and Distress Among Medical Students by JAMA Author Interviews
10 min listen
Putting the Public Back in Public Reporting of Health Care Quality: Interview with Tara Lagu, MD, MPH, author of Putting the Public Back in Public Reporting of Health Care Quality by JAMA Author Interviews
8 min listen
Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making: Interview with Daniel P. Sulmasy, MD, PhD, author of Substituted Interests and Best Judgments: An Integrated Model of Surrogate Decision Making by JAMA Author Interviews
6 min listen
Societal Perceptions of Physicians: Knights, Knaves, or Pawns?: Interview with Sachin H. Jain, MD, MBA and Christine K. Cassel, MD, authors of Societal Perceptions of Physicians: Knights, Knaves, or Pawns? by JAMA Author Interviews
9 min listen
Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women: Interview with Katie L. Stone, PhD, author of Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women by JAMA Author Interviews
3 min listen
Re"evolutionary" Regenerative Medicine: Interview with Helen M. Blau, PhD, author of Re"evolutionary" Regenerative Medicine by JAMA Author Interviews
12 min listen
Discussing Radiation Risks Associated With CT Scans With Patients: Interview with Mark Otto Baerlocher, MD, author of Discussing Radiation Risks Associated With CT Scans With Patients by JAMA Author Interviews
10 min listen
How to Enroll Participants in Research Ethically: Interview with David Wendler, PhD, author of How to Enroll Participants in Research Ethically by JAMA Author Interviews
7 min listen
Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment by JAMA Author Interviews
11 min listen
Active Surveillance for Prostate Cancer: Interview with Ian M. Thompson, MD, author of Active Surveillance for Prostate Cancer by JAMA Author Interviews
9 min listen
he United States' Engagement in Global Tobacco Control: Interview with Lawrence O. Gostin, JD, author of The United States' Engagement in Global Tobacco Control by JAMA Author Interviews
8 min listen
A Vision for Patient-Centered Health Information Systems: Interview with Alex H. Krist, MD, MPH, author of A Vision for Patient-Centered Health Information Systems by JAMA Author Interviews
15 min listen
Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients: Interview with Sunil V. Rao, MD, author of Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients by JAMA Author Interviews
8 min listen
Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes: Interview with Mihai Gheorghiade, MD, author of Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes by JAMA Author Interviews
8 min listen
Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students: Interview with Julie A. Freischlag, MD, author of Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students by JAMA Author Interviews
8 min listen
Patient-Physican Communication: It's About Time: Interview with Wendy Levinson, MD, author of Patient-Physican Communication: It's About Time by JAMA Author Interviews
10 min listen
Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals: Interview with Ryan Radecki, MD, author of Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals by JAMA Author Interviews
6 min listen
Damage Prevention and Control for Financial Incapacity: Interview with Charles Sabatino, JD, author of Damage Prevention and Control for Financial Incapacity by JAMA Author Interviews
8 min listen
A Physician Management Infrastructure: Interview with Peter J. Pronovost, MD, PhD, author of A Physician Management Infrastructure by JAMA Author Interviews
10 min listen
Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial: Interview with Kevin T. McVary, MD, author of Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial by JAMA Author Interviews
5 min listen
From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep: Interview with Benjamin Djulbegovic, MD, PhD, author of From Efficacy to Effectiveness in the Face of Uncertainty: Indication Creep and Prevention Creep by JAMA Author Interviews
9 min listen
Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are: Interview with Charles Hoge, MD, author of Interventions for War-Related Posttraumatic Stress Disorder: Meeting Veterans Where They Are by JAMA Author Interviews
7 min listen
Prevention of Melanoma With Regular Sunscreen Use: Interview with June K. Robinson, MD, author of Prevention of Melanoma With Regular Sunscreen Use by JAMA Author Interviews
11 min listen
National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008: Interview with Jersey Chen, MD, MPH, author of National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 by JAMA Author Interviews
6 min listen
Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers: Interview with Scott V. Masten, PhD, author of Graduated Driver Licensing and Fatal Crashes Involving 16- to 19-Year-Old Drivers by JAMA Author Interviews
4 min listen
Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial: Interview with David J. A. Jenkins, MD, author of Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial by JAMA Author Interviews
8 min listen
A New Frontier in Patient Safety: Interview with Don Berwick, MD, author of A New Frontier in Patient Safety by JAMA Author Interviews
8 min listen

More Episodes from JAMA Author Interviews

Skip carousel

Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: When initial treatment with varenicline or nicotine replacement doesn't work, does increasing dosage improve smoking cessation rates? Paul Cinciripini, PhD, of MD Anderson Cancer Center's Department of Behavioral Science, joins JAMA Executive Editor... by JAMA Author Interviews
11 min listen
Examining Mortality Disparities by Sexual Orientation Among Female Nurses: Extensive evidence documents health disparities for lesbian, gay, and bisexual (LGB) women, including worse physical, mental, and behavioral health than heterosexual women. Sarah McKetta, ScM, MD, PhD, discusses these factors and their link to... by JAMA Author Interviews
8 min listen
Stewardship Prompts to Improve Antibiotic Selection for Pneumonia and Urinary Tract Infection: Can real-time EHR–generated recommendations safely reduce antibiotic use in hospitalized patients with pneumonia or UTI? Shruti K. Gohil, MD, MPH, of the University of California-Irvine, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss... by JAMA Author Interviews
9 min listen
Advancing Climate Action Through Academic Health Systems: Climate action is an urgent public health imperative. Climate change is causing excess morbidity and mortality and posing an increasing threat to mental health and well-being. The US health care sector is a significant contributor to this problem. A.... by JAMA Author Interviews
11 min listen
The Evolution of Screening Tools for Prostate Cancer: The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer... by JAMA Author Interviews
12 min listen
Regional Interventions to Prevent Multidrug-Resistant Organisms: Infections due to multidrug-resistant organisms (MDROs) are difficult to treat with increased morbidity, mortality, length of hospitalization, and health care costs. Author Susan S. Huang, MD, MPH, from the University of California Irvine School of... by JAMA Author Interviews
10 min listen
Mifepristone–Science, Abortion Care, and Politics: The US Supreme Court will soon decide a case challenging the US Food and Drug Administration’s (FDA’s) approval of mifepristone. Author Holly Fernandez Lynch, JD, MBE, University of Pennsylvania, joins JAMA Executive Editor Gregory Curfman, MD, to... by JAMA Author Interviews
19 min listen
How Do Multimodal Large Language Models Perform on Clinical Vignette Questions?: How did GPT-4 Vision, a model that can work with images and text as input, perform when answering clinical challenge questions from medical journals? Daniel Truhn, MD, MSc, of the University Hospital Aachen in Germany, joins JAMA Editor in Chief... by JAMA Author Interviews
9 min listen
Does Treating Attention-Deficit/Hyperactivity Disorder Reduce Mortality?: An observational study by Lin Li, PhD, and colleagues, published in JAMA, found that pharmacotherapy was associated with reduced mortality in individuals with ADHD. Frances R. Levin, MD, of the Columbia Vagelos College of Physicians and Surgeons, who... by JAMA Author Interviews
14 min listen
Delivering Effective Messages in the Patient-Clinician Encounter: Introducing JAMA's new Communicating Medicine series, JAMA Associate Editor Anne Cappola, MD, ScM, discusses strategies for delivering effective messages in the patient encounter with authors Joseph Cappella, PhD, of the University of Pennsylvania,... by JAMA Author Interviews
13 min listen
Why Does PrEP Use Lag in Cisgender Women?: How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content: by JAMA Author Interviews
11 min listen
Updated Pediatric Sepsis Criteria—Transitioning From SIRS to Phoenix: JAMA Associate Editor Romain Pirracchio, MD, MPH, discusses context and implications of the new pediatric sepsis criteria with authors Hallie Prescott, MD, MSc, of the University of Michigan and Ann Arbor VA Hospital, and Roberto Jabornisky, MD, of... by JAMA Author Interviews
14 min listen
Renter Eviction, Excess Mortality, and COVID-19: Renters who received eviction filings experienced excess mortality associated with the COVID-19 pandemic. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discusses a recent study that underscores the importance of studying health outcomes... by JAMA Author Interviews
12 min listen
Azithromycin to Prevent Childhood Mortality in Sub-Saharan Africa: Childhood death rates remain high in some areas of sub-Saharan Africa, despite global reductions in childhood mortality. JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Thomas Lietman, MD, University of California, San Francisco, discuss... by JAMA Author Interviews
11 min listen
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents: Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease... by JAMA Author Interviews
12 min listen
Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision: Following the Dobbs decision, females aged 18-45 years living in states with “trigger laws” that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA... by JAMA Author Interviews
14 min listen
Patient-Centered Palliative Care: JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Alexander K. Smith, MD, MS, MPH, University of California, San Francisco, discuss the importance of 2 new palliative care trials that were recently published in JAMA. Related Content: by JAMA Author Interviews
15 min listen
Dialysis Facility Performance and Social Risk in the First Year of the ESRD Treatment Choices Model: Dialysis facilities in the US are financially rewarded for higher rates of home dialysis and kidney transplant, but facilities that serve patients with high social risk might have a harder time meeting these goals. JAMA Associate Editor Karen E. Joynt... by JAMA Author Interviews
14 min listen
Alpha-Gal Syndrome: Alpha-gal syndrome is a food allergy to red meat products that develops after affected individuals are bitten by a tick. JAMA Deputy Editor Kristin Walter, MD, MS, discusses alpha-gal syndrome with author Mariel R. Benjamin, MD, assistant professor in... by JAMA Author Interviews
9 min listen
Private Equity Acquisition and Hospital-Acquired Adverse Events in the US: The effects of private equity acquisition of US hospitals on the quality of inpatient care and patient outcomes remain largely unknown. JAMA Associate Editor Karen E. Joynt Maddox, MD, MPH, spoke with author Zirui Song, MD, PHD, of Boston General... by JAMA Author Interviews
13 min listen
Effect of Dietary Sodium on Blood Pressure: Does reducing dietary sodium benefit patients already taking antihypertensive medication? JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, speaks with author Norrina Allen, PhD, MPH, from Northwestern University, about the effect of dietary... by JAMA Author Interviews
14 min listen
Risks Associated With Cannabis Exposure During Pregnancy: Cannabis use is increasing among reproductive-age individuals. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the associated risks of cannabis exposure during pregnancy with Torri D. Metz, MD, MS, University of Utah Health. Related Content: by JAMA Author Interviews
10 min listen
Neonatal Outcomes Following Serial Amnioinfusions for Bilateral Renal Agenesis: Bilateral renal agenesis results in lethal neonatal pulmonary hypoplasia. New evidence from an amnioinfusion trial is available. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses the results from the Renal Anhydramnios Fetal Therapy Trial with... by JAMA Author Interviews
13 min listen
Increasing Cervical Cancer Screening With Self-Sampling HPV Kits at Home: Cervical cancer screening is effective when done as recommended. JAMA Deputy Editor Linda Brubaker, MD, speaks with Rachel L. Winer, PhD, MPH, of the University of Washington, about a recent trial in JAMA that compared cervical cancer screening... by JAMA Author Interviews
10 min listen
Small-Volume Blood Collection Tubes May Reduce Transfusions in Intensive Care: Small-volume blood collection tubes may decrease red blood cell transfusions in intensive care units without affecting laboratory analysis. JAMA Associate Editor Christopher W. Seymour, MD, MSc, discusses the results and implications of the STRATUS... by JAMA Author Interviews
17 min listen
Fitness Trackers to Guide Advice on Activity Prescription: Fitness trackers are a group of devices including watches, phones, and rings that track physical activity. JAMA Executive Editor Gregory Curfman, MD, speaks with I-Min Lee, MBBS, ScD, professor of medicine at Harvard Medical School and professor of... by JAMA Author Interviews
15 min listen
Medicare’s Historic Prescription Drug Price Negotiations: JAMA Senior Editor Kristin Walter, MD, MS, and Lawrence O. Gostin, JD, JAMA Legal and Global Health Correspondent and Faculty Director of the O’Neill Institute for National and Global Health Law at Georgetown University, discuss the Inflation... by JAMA Author Interviews
15 min listen
Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart: JAMA Executive Editor Gregory Curfman, MD, speaks with Richard G. Bach, MD, professor of medicine and medical director of the cardiac intensive care unit at the Washington University School of Medicine in St. Louis, about the use of traditional... by JAMA Author Interviews
19 min listen
Optical Coherence Tomography (OCT): Imaging Modalities in Clinical Practice: Optical coherence tomography (OCT) is a powerful imaging tool used across multiple clinical disciplines. JAMA Executive Editor Gregory Curfman, MD, speaks with 2023 Lasker Award recipient James G. Fujimoto, PhD, professor of electrical engineering at... by JAMA Author Interviews
12 min listen
Nasal Iodophor vs Nasal Mupirocin With Chlorhexidine Baths to Prevent Infections in Adult ICUs: Nasal mupirocin plus chlorhexidine baths in ICUs prevents methicillin-resistant Staphylococcus aureus (MRSA) infections but raises concern about antibiotic resistance. JAMA Senior Editor Kristin Walter, MD, speaks with Susan Huang, MD, of University... by JAMA Author Interviews
14 min listen

Related podcast episodes

Skip carousel

Coronavirus Q&A With Anthony Fauci, MD: NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020. Related Article(s): by Coronavirus (COVID-19) Q&A
27 min listen
Coronavirus Q&A With Anthony Fauci, MD – August 3, 2020: Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020. Related Article(s): by JAMA Author Interviews
29 min listen
Coronavirus Q&A With Anthony Fauci, MD – August 3, 2020: Anthony Fauci, MD, White House Coronavirus Task Force member and director of the National Institute of Allergy and Infectious Diseases, discusses latest developments in the COVID-19 pandemic. Recorded August 3, 2020. Related Article(s): by Coronavirus (COVID-19) Q&A
29 min listen
COVID-19 Update With NIAID's Anthony Fauci, MD; March 6, 2020: Coronavirus testing, mortality, vaccine development, containment vs mitigation, and more. JAMA Editor Howard Bauchner, MD, interviews US NIAID Director Anthony Fauci, MD, about the latest developments in SARS-CoV-2 science and global spread of infection. by JAMA Author Interviews
32 min listen
COVID-19 Update With NIAID's Anthony Fauci, MD; March 6, 2020: Coronavirus testing, mortality, vaccine development, containment vs mitigation, and more. JAMA Editor Howard Bauchner, MD, interviews US NIAID Director Anthony Fauci, MD, about the latest developments in SARS-CoV-2 science and global spread of infection. by Coronavirus (COVID-19) Q&A
32 min listen
COVID-19 Update with NIAID’s Anthony Fauci, MD; March 18, 2020: Diagnostic testing, NSAIDs, ACE Inhibitors, antivirals, and more. Anthony Fauci, MD from NIAID discusses latest developments in the spread and clinical management of COVID-19 and the SARS-CoV-2 virus with JAMA Editor Howard Bauchner, MD. by Coronavirus (COVID-19) Q&A
29 min listen
COVID-19 Update with NIAID’s Anthony Fauci, MD; March 18, 2020: Diagnostic testing, NSAIDs, ACE Inhibitors, antivirals, and more. Anthony Fauci, MD from NIAID discusses latest developments in the spread and clinical management of COVID-19 and the SARS-CoV-2 virus with JAMA Editor Howard Bauchner, MD. by JAMA Author Interviews
29 min listen
COVID-19 Update From China: By mid-February 2020 there were 60,000 confirmed cases of COVID-19, the vast majority diagnosed in Hubei Province (including Wuhan city) in mainland China. China CDC Chief Epidemiologist Zunyou Wu, MD, PhD discusses the latest COVID-19 developments in... by Coronavirus (COVID-19) Q&A
26 min listen
COVID-19 Update From China: By mid-February 2020 there were 60,000 confirmed cases of COVID-19, the vast majority diagnosed in Hubei Province (including Wuhan city) in mainland China. China CDC Chief Epidemiologist Zunyou Wu, MD, PhD discusses the latest COVID-19 developments in... by JAMA Author Interviews
26 min listen
MERCOLA.COM: Liars, Propagandists and The Great Reset by SURVIVING HEALTHCARE
18 min listen
The pandemic anniversary: What we’ve learned about health care, science, and ourselves by Next Question with Katie Couric
39 min listen
Anthony Fauci on COVID-19, scientific communication, and the future by The Lancet Voice
30 min listen
Diagnosis, Prevention, and Treatment of Monkeypox by JAMA Clinical Reviews
18 min listen
Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020: Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020. Related Article(s): by Coronavirus (COVID-19) Q&A
37 min listen
Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020: Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020. Related Article(s): by JAMA Author Interviews
37 min listen
Update on Coronavirus: March 6, 2020, by NIAID’s Anthony Fauci, MD: Coronovirus (the virus SARS-CoV-2) continues to spread throughout the world. In recent weeks, there has been an increasing number of cases and deaths in the US. As concern about the virus increases, there is an increasing need for accurate information... by JAMA Clinical Reviews
33 min listen
The latest research on long COVID symptoms, treatments & more with Andrea Garcia, JD, MPH: AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses the latest research on long COVID, as well as #omicron variant XBB.1.5 and other #SARSCoV2 subvariants. Also covering how the Biden Administration's decision to end COVID-19 national emergency and U.S. public health emergency on May 11 will affect hospitals, physicians and patients—while the World Health Organization (WHO) maintains the COVID-19 pandemic is still a global health emergency. American Medical Association CXO Todd Unger hosts. Watch, read, or listen to Sandra Fryhofer, MD, AMA Board Chair's recent #vaccine and bivalent booster episode, here: https://www.ama-assn.org/delivering-care/public-health/bivalent-vaccine-effectiveness-covid-booster-schedule-and-evusheld by AMA Update
13 min listen
Dr. Fauci's Pandemic Prognosis: Guest: Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health | Chief Medical Advisor to President Joe Biden by GZERO World with Ian Bremmer
25 min listen
Coronavirus Vaccine Update From the FDA: Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an... by Coronavirus (COVID-19) Q&A
32 min listen
Coronavirus Vaccine Update From the FDA: Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an... by JAMA Author Interviews
32 min listen
New Definition of Fully Vaccinated is “On the Table”: Dr. Anthony Fauci, White House chief medical advisor, weighs in on holiday parties with vaccinated family and friends as Covid-19 omicron variant spreads throughout the United States. The nation’s top infectious disease doctor discusses a possible redefinition of what it means to be fully vaccinated against Covid-19. Changes are certainly “on the table,” said Dr. Fauci, who emphasizes there is no doubt that optimum vaccination is with a booster dose. Currently, individuals are considered to be fully vaccinated either two weeks after their second dose of a two-dose series, such as the Pfizer-BioNtech vaccine, or two weeks after a single-dose vaccine, such as the Johnson & Johnson vaccine. Plus, an e-commerce boon for Fed-Ex during the holiday season and a major change in the legal battles against the makers of Oxycontin. In this episode: Dr. Anthony Fauci Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrso by Squawk Pod
31 min listen
Viral Mutations: A Balancing Act Between Transmission & Virulence by Public Health Insight
13 min listen
Global COVID-19 Update: In July 2022, Nahid Bhadelia, MD, MALD, joined the White House COVID-19 Response Team as senior policy advisor for Global COVID Response. The infectious disease physician, who is on sabbatical from Boston University, spoke with JAMA Associate Managing... by JAMA Medical News
20 min listen
Global COVID-19 Update: In July 2022, Nahid Bhadelia, MD, MALD, joined the White House COVID-19 Response Team as senior policy advisor for Global COVID Response. The infectious disease physician, who is on sabbatical from Boston University, spoke with JAMA Associate Managing... by Coronavirus (COVID-19) Q&A
20 min listen
Monkeypox, Omicron BA.5, and Novavax with Andrea Garcia, JD, MPH: AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, details summer spike of COVID-19 cases driven by the highly transmissible Omicron BA.5 subvariant. Also covering Novavax news, as well as monkeypox cases and stats—including the World Health Organization (WHO) declaring it a global health emergency. American Medical Association CXO Todd Unger hosts. by AMA Update
11 min listen
Coronavirus Update From the WHO by Coronavirus (COVID-19) Q&A
42 min listen
Coronavirus Update From the WHO: Soumya Swaminathan, MD, DNB, chief scientist at the World Health Organization (WHO), discusses the global coronavirus pandemic and the WHO response. Recorded August 5, 2020. Related Article: by JAMA Author Interviews
42 min listen
COVID-19 CDC Update – Early January 2022: Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the... by JAMA Author Interviews
32 min listen
COVID-19 CDC Update – Early January 2022: Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the... by Coronavirus (COVID-19) Q&A
32 min listen
COVID-19: Is the end in sight?: Dr Anthony Fauci and other experts tell us why Omicron might - but only might - mean we are in the end-game in the fight against COVID. Alongside him at the Davos Agenda session ‘COVID-19 - What’s Next?’ are Professor Annelies Wilder-Smith,... by Radio Davos
49 min listen

Discover this podcast and so much more

Coronavirus Q&A With Anthony Fauci, MD

Coronavirus Q&A With Anthony Fauci, MD

Description

Titles in the series (100)

More Episodes from JAMA Author Interviews

Related podcast episodes